Chirocane 2.5mg. 5mg. 7mg Injection
PDF Leaflet Revision Date: 7 July 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Surgical anaesthesia and pain management.
Dosage (summary)
Adults: 50-150 mg for epidural; 1-60 ml for local infiltration. Max 2 mg/kg.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; may cause maternal and fetal toxicity.
Key Drug Interactions
- CYP3A4 inducers
- CYP3A4 inhibitors
- Other local anaesthetics
Contraindications
- Hypersensitivity to levobupivacaine
- Severe renal impairment
- Severe hepatic impairment
Common side effects
- Hypotension
- Nausea
- Dizziness
- Convulsions
Counselling Points
- Avoid driving until effects of anaesthesia wear off
- Monitor for signs of CNS toxicity
- Seek immediate help for severe reactions
Serious warnings
- Risk of cardiac arrest with IV injection
- Use caution in hypotension
- Incremental dosing recommended
Important Disclaimer
The Chirocane 2.5mg. 5mg. 7mg Injection professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
